Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE).

Adult Age Factors Aged Case-Control Studies Female Head and Neck Neoplasms / epidemiology Humans Male Middle Aged Risk Factors Nicotiana / adverse effects
Age at start of tobacco use Head and neck cancer Hypopharyngeal cancer Laryngeal cancer Oral cancer Oropharyngeal cancer

Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
12 2019
Historique:
received: 14 06 2019
revised: 18 09 2019
accepted: 19 09 2019
pubmed: 7 10 2019
medline: 24 4 2020
entrez: 7 10 2019
Statut: ppublish

Résumé

Tobacco use is a well-established risk factor for head and neck cancer (HNC). However, less is known about the potential impact of exposure to tobacco at an early age on HNC risk. We analyzed individual-level data on ever tobacco smokers from 27 case-control studies (17,146 HNC cases and 17,449 controls) in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using random-effects logistic regression models. Without adjusting for tobacco packyears, we observed that younger age at starting tobacco use was associated with an increased HNC risk for ever smokers (OR Results from this pooled analysis suggest that increased HNC risks observed with earlier age at starting tobacco smoking are largely due to longer duration and higher cumulative tobacco exposures.

Sections du résumé

BACKGROUND
Tobacco use is a well-established risk factor for head and neck cancer (HNC). However, less is known about the potential impact of exposure to tobacco at an early age on HNC risk.
METHODS
We analyzed individual-level data on ever tobacco smokers from 27 case-control studies (17,146 HNC cases and 17,449 controls) in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using random-effects logistic regression models.
RESULTS
Without adjusting for tobacco packyears, we observed that younger age at starting tobacco use was associated with an increased HNC risk for ever smokers (OR
CONCLUSIONS
Results from this pooled analysis suggest that increased HNC risks observed with earlier age at starting tobacco smoking are largely due to longer duration and higher cumulative tobacco exposures.

Identifiants

DOI: 10.1016/j.canep.2019.101615 PMID: 31586822 PMC: PMC10072232
pubmed: 31586822
pii: S1877-7821(19)30126-2
doi: 10.1016/j.canep.2019.101615
pmc: PMC10072232
mid: NIHMS1544042
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

101615

Subventions

Organisme : NCI NIH HHS
ID : K07 CA104231
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100264
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA011386
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES011667
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE013110
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA077954
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100679
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA090388
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA113157
Pays : United States
Organisme : NIDCR NIH HHS
ID : R03 DE016611
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA096134
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA030022
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA078609
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA068384
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE013158
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009142
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Cancer Causes Control. 2011 Jul;22(7):1037-46
pubmed: 21607590
Oral Oncol. 2015 Aug;51(8):727-30
pubmed: 26066977
Cancer Sci. 2011 Feb;102(2):460-7
pubmed: 21129124
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):696-703
pubmed: 16614111
Int J Cancer. 2006 Feb 1;118(3):714-20
pubmed: 16094634
Am J Epidemiol. 1995 Dec 15;142(12):1255-64
pubmed: 7503045
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1091-4
pubmed: 14578148
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Cancer. 1998 Aug 31;77(5):705-9
pubmed: 9688303
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Int J Epidemiol. 1991 Dec;20(4):845-51
pubmed: 1800421
Br J Cancer. 2001 Jul 6;85(1):46-54
pubmed: 11437401
Int J Cancer. 2004 Mar 1;108(6):907-11
pubmed: 14712496
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1188-93
pubmed: 15894670
Int J Cancer. 2013 Apr 15;132(8):1911-7
pubmed: 22987222
Cancer Res. 1989 Sep 1;49(17):4919-24
pubmed: 2758421
BMC Med. 2009 Jul 29;7:36
pubmed: 19638245
Cancer Res. 2004 Jun 1;64(11):4049-54
pubmed: 15173020
J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
pubmed: 14652239
Cancer Causes Control. 2002 Dec;13(10):957-64
pubmed: 12588092
Int J Cancer. 1989 Jun 15;43(6):992-1000
pubmed: 2732011
Cancer Sci. 2006 Aug;97(8):760-7
pubmed: 16800818
Cancer Res. 1990 Oct 15;50(20):6502-7
pubmed: 2208109
J Natl Cancer Inst. 1999 Apr 7;91(7):614-9
pubmed: 10203280
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):476-82
pubmed: 15734975
J Oral Pathol Med. 2004 Oct;33(9):525-32
pubmed: 15357672
Lancet Oncol. 2008 Jul;9(7):667-75
pubmed: 18598931
Int J Epidemiol. 1991 Dec;20(4):878-85
pubmed: 1800426
Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):185-91
pubmed: 10698480
Cancer Causes Control. 1999 Feb;10(1):27-33
pubmed: 10334639
Carcinogenesis. 2002 Jul;23(7):1229-34
pubmed: 12117782
Oral Dis. 2015 Sep;21(6):685-93
pubmed: 25809224
Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):189-93
pubmed: 8318870
Am J Epidemiol. 2016 Nov 15;184(10):703-716
pubmed: 27744388
Annu Rev Med. 2016;67:91-101
pubmed: 26332002
Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):305-12
pubmed: 8348053
Int J Cancer. 2004 Feb 20;108(5):766-72
pubmed: 14696105
J Clin Epidemiol. 2006 Jan;59(1):82-9
pubmed: 16360565
Cancer Res. 1996 Nov 15;56(22):5192-7
pubmed: 8912856
Am J Epidemiol. 2002 Nov 1;156(9):813-23
pubmed: 12396999
J Natl Cancer Inst. 1993 Mar 17;85(6):465-73
pubmed: 8445674
J Epidemiol Community Health. 2011 Aug;65(8):709-14
pubmed: 20724282
BMC Cancer. 2009 May 08;9:137
pubmed: 19426493
Cancer. 1998 Apr 1;82(7):1367-75
pubmed: 9529030
Laryngoscope. 1997 Jun;107(6):765-81
pubmed: 9185733
Int J Cancer. 2004 Dec 10;112(5):901-4
pubmed: 15386379
Cancer Res. 1988 Jun 1;48(11):3282-7
pubmed: 3365707
Int J Cancer. 2002 Mar 20;98(3):440-5
pubmed: 11920597
Eur J Cancer Prev. 2003 Feb;12(1):25-33
pubmed: 12548107
Eur J Cancer Prev. 2004 Jun;13(3):165-72
pubmed: 15167214
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):541-50
pubmed: 19190158
Oral Oncol. 2019 Jul;94:47-57
pubmed: 31178212
Cancer Causes Control. 2010 Apr;21(4):567-75
pubmed: 20049634
Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1095-100
pubmed: 10613342

Auteurs

Chun-Pin Chang (CP)

Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, UT, United States.

Shen-Chih Chang (SC)

International Agency for Research on Cancer, Lyon, France; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, United States.

Shu-Chun Chuang (SC)

Institute of Population Health Sciences, National Health Research Institutes, Taiwan.

Julien Berthiller (J)

International Agency for Research on Cancer, Lyon, France; Pôle Information Médicale Evaluation Recherche, Hospices Civils de Lyon, France.

Gilles Ferro (G)

International Agency for Research on Cancer, Lyon, France.

Keitaro Matsuo (K)

Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan; Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Victor Wünsch-Filho (V)

Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil.

Tatiana N Toporcov (TN)

Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil.

Marcos Brasilino de Carvalho (MB)

Department of Head and Neck, Heliopolis Hospital, São Paulo, Brazil.

Carlo La Vecchia (C)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Andrew F Olshan (AF)

Department of Epidemiology, Gillings School of Global Public Health, Chapel Hill, NC, United States.

Jose P Zevallos (JP)

Division of Head and Neck Surgical Oncology, Department of Otolaryngology/Head and Neck Surgery, Washington University School of Medicine, Saint Louis, MO, United States.

Diego Serraino (D)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy.

Joshua Muscat (J)

Penn State College of Medicine, Hershey, PA, United States.

Erich M Sturgis (EM)

University of Texas M. D. Anderson Cancer Center, Houston, TX, United States.

Guojun Li (G)

University of Texas M. D. Anderson Cancer Center, Houston, TX, United States.

Hal Morgenstern (H)

Departments of Epidemiology and Environmental Health Sciences, School of Public Health, and Department of Urology, Medical School, University of Michigan, Ann Arbor, MI, United States.

Fabio Levi (F)

Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Luigino Dal Maso (L)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy.

Elaine Smith (E)

College of Public Health, University of Iowa, Iowa City, IA, United States.

Karl Kelsey (K)

Brown University, Providence, RI, United States.

Michael McClean (M)

Brown University, Providence, RI, United States.

Thomas L Vaughan (TL)

Fred Hutchinson Cancer Research Center, Seattle, WA, United States.

Philip Lazarus (P)

Washington State University College of Pharmacy, Spokane, WA, United States.

Heribert Ramroth (H)

University of Heidelberg, Heidelberg, Germany.

Chu Chen (C)

Fred Hutchinson Cancer Research Center, Seattle, WA, United States.

Stephen M Schwartz (SM)

Fred Hutchinson Cancer Research Center, Seattle, WA, United States.

Deborah M Winn (DM)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.

Cristina Bosetti (C)

Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Valeria Edefonti (V)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Werner Garavello (W)

Department of Otorhinolaryngology, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Eva Negri (E)

Department of Biomedical and Clinical Sciences, University of Milan, Italy.

Richard B Hayes (RB)

Division of Epidemiology, New York University School of Medicine, New York, United States.

Mark P Purdue (MP)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.

Stefania Boccia (S)

Institute of Public Health, Section of Hygiene, Universita Cattolica del Sacro Cuore, Rome, Italy; Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.

Gabriella Cadoni (G)

Department of Head and Neck Surgery, Institute of Clinical Otorhinolaryngology, Università Cattolica del Sacro Cuore, Rome, Italy; Istituto di Clinica Otorinolaringoiatrica, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.

Oxana Shangina (O)

Cancer Research Centre, Moscow, Russia.

Rosalina Koifman (R)

Escola Nacional de Suade Publica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.

Maria Paula Curado (MP)

ACCAMARGO Cancer Center, São Paulo, Brazil.

Marta Vilensky (M)

Institute of Oncology Angel H. Roffo, University of Buenos Aires, Argentina.

Beata Swiatkowska (B)

Nofer Institute of Occupational Medicine, Lodz, Poland.

Rolando Herrero (R)

International Agency for Research on Cancer, Lyon, France.

Silvia Franceschi (S)

Scientific Directorate, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy.

Simone Benhamou (S)

National Institute of Health and Medical Research, Inserm U1018, Villejuif, France.

Leticia Fernandez (L)

Institute of Oncology and Radiobiology, Havana, Cuba.

Ana M B Menezes (AMB)

Universidade Federal de Pelotas, Pelotas, Brazil.

Alexander W Daudt (AW)

Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.

Dana Mates (D)

National Institute of Public Health, Bucharest, Romania.

Stimson Schantz (S)

New York Eye and Ear Infirmary, New York, NY, United States.

Guo-Pei Yu (GP)

Department of Otolaryngology, School of Medicine, New York Medical College, Valhalla, NY, United States.

Jolanta Lissowska (J)

The M. Skasodowska-Curie Memorial Cancer Center and Institute of Oncology, Dept. of Cancer Epidemiology and Prevention, Warsaw, Poland.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Eleonora Fabianova (E)

Regional Authority of Public Health in Banska Bystrica, Slovakia.

Peter Rudnai (P)

National Institute of Environmental Health, Budapest, Hungary.

Paul Brennan (P)

International Agency for Research on Cancer, Lyon, France.

Paolo Boffetta (P)

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Zuo-Feng Zhang (ZF)

Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, United States.

Mia Hashibe (M)

Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, UT, United States.

Yuan-Chin Amy Lee (YA)

Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, UT, United States. Electronic address: amy.lee@utah.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Age at start of using tobacco on the risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Facteurs âges › Age at start of using tobacco on the risk of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Age at start of using tobacco on the risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › Age at start of using tobacco on the risk of...
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Age at start of using tobacco on the risk of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Age at start of using tobacco on the risk of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Age at start of using tobacco on the risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Age at start of using tobacco on the risk of...